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Cancer is one of the most feared diseases in the world in which it is difficultly treated without 
close attention. This is because it is hard to synthesize agents that could detect and invade these 
cells. Among all the therapies that was developed to treat this mortal disease, including 
chemotherapy, hormone therapy and radiation therapy, the only best treatment with the least 
adverse and fatalistic effects is the immunotherapy in which it assist in boosting the immune 
system to specifically target the cancerous cells. Even though the immune system has evolved over 
the years to detect and eliminate any viral or non-viral (bacterial) infections, they are hard to detect 
cancerous cells without any assistance, because they were originally healthy, normal cells that 
have transformed into pathogenic cells through mutations, thus they are hard to be differentiated. 
However, on the surface of these cancer cells, they compose a distinct, complex component, a 
tumor associated carbohydrate antigens (TACAs) that differentiate them from normal, healthy 
adult tissues. Therefore, the main focus of this project is to synthesize anti-cancer vaccine, which 
is mainly composed of acetyl-free carbohydrates, that could instruct the immune system to 
recognize and target specifically the cancerous cells. Unfortunately, not all carbohydrates have the 
ability to target cells because they are sensitive to enzymatic process and are capable to degrade at 
different environmental conditions. So, the best option is to remove the acetyl group in the 
carbohydrate by exchanging the exocyclic oxygen with a methyl group (C-glycoside) to synthesize 
an acetyl-free C-glycoside which is identical to the TF-antigen found primarily and solitary in 
cancerous cells. This presentation will discuss about the manifestation and the synthesize of acetyl-
free carbohydrates on the invasion of cancerous cells. 
